CN102895640B - 用于治疗气滞血瘀型变应性鼻炎的中药组合物 - Google Patents
用于治疗气滞血瘀型变应性鼻炎的中药组合物 Download PDFInfo
- Publication number
- CN102895640B CN102895640B CN201210418623.1A CN201210418623A CN102895640B CN 102895640 B CN102895640 B CN 102895640B CN 201210418623 A CN201210418623 A CN 201210418623A CN 102895640 B CN102895640 B CN 102895640B
- Authority
- CN
- China
- Prior art keywords
- weight portions
- radix
- medicine composition
- herba
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 90
- 239000008280 blood Substances 0.000 title claims abstract description 81
- 210000004369 blood Anatomy 0.000 title claims abstract description 78
- 206010039085 Rhinitis allergic Diseases 0.000 title claims abstract description 36
- 201000010105 allergic rhinitis Diseases 0.000 title claims abstract description 36
- 239000003814 drug Substances 0.000 claims description 116
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 76
- 239000000843 powder Substances 0.000 claims description 72
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 71
- 239000000243 solution Substances 0.000 claims description 66
- 239000000706 filtrate Substances 0.000 claims description 65
- 238000011282 treatment Methods 0.000 claims description 49
- 239000009670 cang er zi wan Substances 0.000 claims description 41
- 238000003756 stirring Methods 0.000 claims description 39
- 239000000341 volatile oil Substances 0.000 claims description 33
- 238000001914 filtration Methods 0.000 claims description 32
- 239000007788 liquid Substances 0.000 claims description 25
- 239000007921 spray Substances 0.000 claims description 23
- 239000009636 Huang Qi Substances 0.000 claims description 20
- 240000008669 Hedera helix Species 0.000 claims description 19
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 19
- 239000009090 lianfang Substances 0.000 claims description 19
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 19
- 210000000582 semen Anatomy 0.000 claims description 19
- 238000004821 distillation Methods 0.000 claims description 18
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 18
- 239000002552 dosage form Substances 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 15
- 238000004321 preservation Methods 0.000 claims description 14
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 238000001556 precipitation Methods 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 229920000858 Cyclodextrin Polymers 0.000 claims description 9
- 239000001116 FEMA 4028 Substances 0.000 claims description 9
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 9
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 9
- 229960004853 betadex Drugs 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 9
- 239000003921 oil Substances 0.000 claims description 9
- -1 electuary Substances 0.000 claims description 6
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000007922 nasal spray Substances 0.000 claims description 5
- 229940097496 nasal spray Drugs 0.000 claims description 5
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 5
- 229920000053 polysorbate 80 Polymers 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 239000007902 hard capsule Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000007901 soft capsule Substances 0.000 claims description 3
- 229940098465 tincture Drugs 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 46
- 108090000978 Interleukin-4 Proteins 0.000 abstract description 13
- 206010028748 Nasal obstruction Diseases 0.000 abstract description 9
- 244000183685 Citrus aurantium Species 0.000 abstract 2
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 2
- 102000004388 Interleukin-4 Human genes 0.000 abstract 2
- 241000951473 Schizonepeta Species 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 229940028885 interleukin-4 Drugs 0.000 abstract 2
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 244000141218 Alpinia officinarum Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 235000019510 Long pepper Nutrition 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000003455 Piper longum Species 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 244000042430 Rhodiola rosea Species 0.000 abstract 1
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000004274 Sarcandra glabra Species 0.000 abstract 1
- 241000195974 Selaginella Species 0.000 abstract 1
- 241000329195 Sparganium erectum Species 0.000 abstract 1
- 241000046198 Triteleia hyacinthina Species 0.000 abstract 1
- 241000157352 Uncaria Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 36
- 230000001737 promoting effect Effects 0.000 description 34
- 210000004185 liver Anatomy 0.000 description 28
- 210000004072 lung Anatomy 0.000 description 27
- 208000002193 Pain Diseases 0.000 description 25
- 230000017531 blood circulation Effects 0.000 description 25
- 230000036407 pain Effects 0.000 description 22
- 230000007812 deficiency Effects 0.000 description 20
- 201000010099 disease Diseases 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 210000003734 kidney Anatomy 0.000 description 17
- 210000002784 stomach Anatomy 0.000 description 14
- 210000002216 heart Anatomy 0.000 description 13
- 210000001015 abdomen Anatomy 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 12
- 230000003203 everyday effect Effects 0.000 description 12
- 230000001717 pathogenic effect Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 206010030113 Oedema Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 208000011580 syndromic disease Diseases 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 8
- 230000004087 circulation Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 241000700199 Cavia porcellus Species 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 208000019255 Menstrual disease Diseases 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 210000002850 nasal mucosa Anatomy 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 208000025747 Rheumatic disease Diseases 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 230000009545 invasion Effects 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000001331 nose Anatomy 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000000552 rheumatic effect Effects 0.000 description 5
- 201000009890 sinusitis Diseases 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 208000035861 hematochezia Diseases 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 208000010753 nasal discharge Diseases 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 201000005404 rubella Diseases 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 206010063659 Aversion Diseases 0.000 description 3
- 208000019838 Blood disease Diseases 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 201000005505 Measles Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000003542 behavioural effect Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 208000014951 hematologic disease Diseases 0.000 description 3
- 208000018706 hematopoietic system disease Diseases 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 206010034754 petechiae Diseases 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010052140 Eye pruritus Diseases 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 208000034526 bruise Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 108010067755 dinitrophenyl-bovine serum albumin Proteins 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 230000001861 immunosuppressant effect Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 230000009278 visceral effect Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 101100433727 Caenorhabditis elegans got-1.2 gene Proteins 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- PGLIUCLTXOYQMV-UHFFFAOYSA-N Cetirizine hydrochloride Chemical compound Cl.Cl.C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 PGLIUCLTXOYQMV-UHFFFAOYSA-N 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010039094 Rhinitis perennial Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041954 Starvation Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940088529 claritin Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 210000000222 eosinocyte Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000005182 global health Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940029329 intrinsic factor Drugs 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 208000022719 perennial allergic rhinitis Diseases 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 例数 | 鼻痒 | 鼻堵 | 喷嚏 | 流涕 | |
治疗组 | 治疗前 | 80 | 2.00±0.32 | 1.97±0.48 | 2.40±0.19 | 2.20±0.29 |
治疗后 | 80 | 0.72±0.05 | 0.86±0.11 | 0.96±0.17 | 0.95±0.13 | |
对照组 | 治疗前 | 80 | 1.93±0.18 | 2.17±0.30 | 2.29±0.08 | 2.15±0.09 |
治疗后 | 80 | 1.02±0.17 | 1.21±0.18 | 1.37±0.12 | 1.36±0.16 |
组别 | 例数 | 疗前积分 | 疗后积分 |
治疗组 | 80 | 2.10±0.11 | 0.79±0.09 |
对照组 | 80 | 1.98±0.13 | 1.29±0.14 |
组别 | 例数 | 疗前积分 | 疗后积分 |
治疗组 | 80 | 6.26±0.71 | 2.31±0.26 |
对照组 | 80 | 6.03±0.42 | 3.47±0.28 |
组别 | 例数 | 显效 | 有效 | 无效 | 总有效率 |
治疗组 | 80 | 67 | 12 | 1 | 98.8% |
对照组 | 80 | 42 | 27 | 11 | 86.3% |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210418623.1A CN102895640B (zh) | 2012-10-26 | 2012-10-26 | 用于治疗气滞血瘀型变应性鼻炎的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210418623.1A CN102895640B (zh) | 2012-10-26 | 2012-10-26 | 用于治疗气滞血瘀型变应性鼻炎的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102895640A CN102895640A (zh) | 2013-01-30 |
CN102895640B true CN102895640B (zh) | 2014-07-23 |
Family
ID=47568325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210418623.1A Expired - Fee Related CN102895640B (zh) | 2012-10-26 | 2012-10-26 | 用于治疗气滞血瘀型变应性鼻炎的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102895640B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103223157B (zh) * | 2013-05-20 | 2014-09-03 | 广州市云桥生物科技有限公司 | 一种用于治疗感冒的中药组合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1145494C (zh) * | 2001-05-18 | 2004-04-14 | 赵文修 | 一种治疗鼻窦炎的药物及其制备方法 |
CN1751730A (zh) * | 2004-09-20 | 2006-03-29 | 曹蛟 | 一种治疗过敏性鼻炎的中药及其制备方法 |
CN101164613B (zh) * | 2007-10-12 | 2010-04-21 | 闫改转 | 一种治疗鼻炎的中成药 |
CN101653529A (zh) * | 2009-09-16 | 2010-02-24 | 长治市郊区黄碾镇中心卫生院 | 一种用于治疗变态反应性鼻炎的药物 |
-
2012
- 2012-10-26 CN CN201210418623.1A patent/CN102895640B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102895640A (zh) | 2013-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103893615B (zh) | 一种具有润肺止咳功效的莱阳梨膏 | |
CN103520694B (zh) | 治疗慢性阻塞性肺病稳定期的中药组合物及其制备方法 | |
CN103120760B (zh) | 用于治疗急性鼻窦炎的中药组合物及其制备方法 | |
CN104771578A (zh) | 用于治疗变应性鼻炎的中药 | |
CN104784549A (zh) | 用于治疗变应性鼻炎的内服中药 | |
CN105412696A (zh) | 治疗肝郁脾虚证型肠易激综合征的药物 | |
CN102895640B (zh) | 用于治疗气滞血瘀型变应性鼻炎的中药组合物 | |
CN104547836A (zh) | 一种治疗老年性痴呆的中药组合物 | |
CN102895519B (zh) | 用于治疗过敏性鼻炎的中药及其制备方法 | |
CN104042766A (zh) | 一种治疗习惯性便秘的中药组合物 | |
CN104398873B (zh) | 一种用于外痔的中药制剂及其制备方法 | |
CN101439150B (zh) | 一种治疗肠炎的中药组合物 | |
CN105435190A (zh) | 用于治疗寒热错杂型哮病的中药组合物及其制备方法 | |
CN104771637A (zh) | 治疗胆结石的利胆排石剂及制备方法 | |
CN104524345A (zh) | 一种治疗小儿湿疹的中药 | |
CN104398789A (zh) | 一种治疗缺铁性贫血的中药汤剂 | |
CN104147573A (zh) | 治疗风感头痛的清热解毒制剂及制法 | |
CN104206597B (zh) | 一种缓解肺肾阴虚症状的五味子保健茶及其制备方法 | |
CN103705856B (zh) | 用于预防放化疗急性放射反应的中药组合物 | |
CN103041194B (zh) | 用于治疗慢性湿疹的中药组合物及其制备方法 | |
CN102908575B (zh) | 用于治疗慢性单纯性鼻炎的内用中药及其制备方法 | |
CN105106775A (zh) | 一种治疗产后大便难的中药制剂及其制备方法 | |
CN105106842A (zh) | 一种用于治疗慢性乙型肝炎的药物 | |
CN105055896A (zh) | 用于治疗精索静脉曲张性不育的药物 | |
CN104645233A (zh) | 一种治疗乳腺增生的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 225400 Jiangsu Province, Taixing City Industrial Park Xiangrong Road No. 18 Patentee after: Jiang Zhixin Address before: 266000 Shandong City, Qingdao Sifang District, No. 104 Nanning Road, building four, unit 502, a family of 2 Patentee before: Jiang Zhixin |
|
TR01 | Transfer of patent right |
Effective date of registration: 20171020 Address after: Lang Jun Center No. 28 road 401120 Chongqing city Yubei District Huanglong longta Street Building 3 2-1 Patentee after: Chongqing AOPO Ruisen Technology Co. Ltd. Address before: 225400 Jiangsu Province, Taixing City Industrial Park Xiangrong Road No. 18 Patentee before: Jiang Zhixin |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180529 Address after: 401120 293 Xingcheng Avenue, Hui Xing street, Yubei District, Chongqing, with 7 buildings 9. Patentee after: CHONGQING XUANNU BIOTECHNOLOGY CO., LTD. Address before: 401120, 3, 2-1, Langjun center, 28 Huanglong Road, Dragon Tower Street, Yubei District, Chongqing. Patentee before: Chongqing AOPO Ruisen Technology Co. Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140723 Termination date: 20191026 |
|
CF01 | Termination of patent right due to non-payment of annual fee |